Cooperative AgreementPostedDiscretionary

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Centers for Disease Control and Prevention - ERA
RFA-TS-26-165
Application Deadline
Jun 10, 2026
Closed
Days Remaining
0
Deadline passed
Award Ceiling
$500,000
Total Program Funding
$4,500,000

Grant Opportunity Analysis

The Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry is seeking cooperative agreement proposals to study and evaluate potential risk factors for amyotrophic lateral sclerosis (ALS). The work centers on human epidemiological investigations of environmental and other ALS risk factors, with interest in military service, contact sports, traumatic brain injury, neuroinflammation, infectious agents, and the Guamanian ALS cluster. The funding opportunity is organized into four options ranging from studies with strong existing evidence to exploratory and population-specific research, and proposals are expected to align with CDC priorities emphasizing rigorous, transparent, evidence-based science. Applications are due June 10, 2026, by 11:59 p.m. ET, with no cost-sharing required and an award ceiling of $500,000, or $300,000 per budget period depending on the funding option.

Eligible Applicants

Unrestricted
Additional Eligibility Information

Additional Eligibility Information to be included in the NOFO.

Grant Documents

1 File

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedMay 11, 2026
deadlineApplication DeadlineJun 10, 2026
expiryArchive DateMay 12, 2027

Funding Details

Award Ceiling
$500,000
Est. Total Program Funding
$4,500,000
Expected Awards
3
No cost sharing required

Agency & Classification

Agency
Centers for Disease Control and Prevention - ERA(HHS-CDC-HHSCDCERA)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

CFDA Numbers

93.061

Official Sources